Compare KREF & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KREF | OFIX |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.7M | 500.2M |
| IPO Year | N/A | 1998 |
| Metric | KREF | OFIX |
|---|---|---|
| Price | $6.42 | $11.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $9.75 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 1.4M | 283.5K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 15.77% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $560.38 | $6.15 |
| Revenue Next Year | $0.36 | $6.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $6.29 | $10.25 |
| 52 Week High | $11.24 | $16.99 |
| Indicator | KREF | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 33.69 | 39.79 |
| Support Level | N/A | $10.75 |
| Resistance Level | $9.42 | $16.38 |
| Average True Range (ATR) | 0.19 | 0.42 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 13.51 | 41.10 |
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.